Published in Curr HIV/AIDS Rep on August 05, 2017
Mild cognitive impairment as a diagnostic entity. J Intern Med (2004) 26.95
Updated research nosology for HIV-associated neurocognitive disorders. Neurology (2007) 16.18
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology (2010) 12.32
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol (2010) 7.56
Alzheimer's disease. N Engl J Med (2004) 7.50
Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS (2010) 4.41
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol (2013) 4.16
Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med (2011) 3.28
The spectrum of behavioral changes in Alzheimer's disease. Neurology (1996) 2.97
Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev (2009) 2.86
Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline. Proc Natl Acad Sci U S A (2005) 2.79
Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD. Neurology (2011) 2.61
Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol (2007) 2.27
Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS (2005) 2.07
The neuropsychological profile of Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.93
CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease. Neurology (2009) 1.85
Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS (2004) 1.84
Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort. J Neuroimmunol (2004) 1.78
CSF amyloid beta42 and tau levels correlate with AIDS dementia complex. Neurology (2005) 1.73
Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study. Neurology (2015) 1.66
Cognitively unimpaired HIV-positive subjects do not have increased 11C-PiB: a case-control study. Neurology (2010) 1.66
Diffusion tensor imaging in Alzheimer's disease and mild cognitive impairment. Behav Neurol (2009) 1.63
Prevalence of Alzheimer plaques in AIDS. J Neurol Neurosurg Psychiatry (1998) 1.62
HIV-associated neurocognitive disorder. Lancet Infect Dis (2013) 1.60
Independent effects of HIV, aging, and HAART on brain volumetric measures. J Acquir Immune Defic Syndr (2012) 1.58
Clinical factors related to brain structure in HIV: the CHARTER study. J Neurovirol (2011) 1.57
White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals. J Neurovirol (2009) 1.57
Increased accumulation of intraneuronal amyloid beta in HIV-infected patients. J Neuroimmune Pharmacol (2009) 1.55
Accelerated Tau deposition in the brains of individuals infected with human immunodeficiency virus-1 before and after the advent of highly active anti-retroviral therapy. Acta Neuropathol (2006) 1.52
White matter abnormalities revealed by diffusion tensor imaging in non-demented and demented HIV+ patients. Neuroimage (2009) 1.52
Motor signs during the course of Alzheimer disease. Neurology (2004) 1.47
HIV-1 Tat inhibits neprilysin and elevates amyloid beta. AIDS (2005) 1.47
Antiretroviral neurotoxicity. J Neurovirol (2012) 1.43
Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection. J Infect Dis (2013) 1.42
Neurobiology of HIV. Int Rev Psychiatry (2008) 1.38
Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study. EBioMedicine (2015) 1.36
Amyloid and tau cerebrospinal fluid biomarkers in HIV infection. BMC Neurol (2009) 1.32
The comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: a foreseeable medical challenge in post-HAART era. J Neuroimmune Pharmacol (2008) 1.31
Neurocognitive consequences of HIV infection in older adults: an evaluation of the "cortical" hypothesis. AIDS Behav (2011) 1.27
Factors affecting brain structure in men with HIV disease in the post-HAART era. Neuroradiology (2011) 1.27
Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients. PLoS One (2014) 1.21
Tau imaging in neurodegenerative diseases. Eur J Nucl Med Mol Imaging (2015) 1.21
Aging exacerbates extrapyramidal motor signs in the era of highly active antiretroviral therapy. J Neurovirol (2008) 1.17
Regional brain structural dysmorphology in human immunodeficiency virus infection: effects of acquired immune deficiency syndrome, alcoholism, and age. Biol Psychiatry (2012) 1.12
Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers. AIDS (2012) 1.09
Controversies in HIV-associated neurocognitive disorders. Lancet Neurol (2014) 1.07
Increased frequency of alpha-synuclein in the substantia nigra in human immunodeficiency virus infection. J Neurovirol (2009) 1.06
Mapping white matter integrity in elderly people with HIV. Hum Brain Mapp (2013) 1.05
PET approaches for diagnosis of dementia. AJNR Am J Neuroradiol (2013) 1.03
Brain aging in acquired immunodeficiency syndrome: increased ubiquitin-protein conjugate is correlated with decreased synaptic protein but not amyloid plaque accumulation. J Neurovirol (2004) 1.00
Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections. J Neurol (2012) 0.99
The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment. Cold Spring Harb Perspect Med (2012) 0.97
Peripheral blood HIV DNA is associated with atrophy of cerebellar and subcortical gray matter. Neurology (2013) 0.97
Deficits in self-awareness impact the diagnosis of asymptomatic neurocognitive impairment in HIV. AIDS Res Hum Retroviruses (2013) 0.96
Small-vessel vascular disease in human immunodeficiency virus infection: the Hawaii aging with HIV cohort study. Cerebrovasc Dis (2007) 0.94
(11)C-PBR28 binding to translocator protein increases with progression of Alzheimer's disease. Neurobiol Aging (2016) 0.94
Mapping cerebellar degeneration in HIV/AIDS. Neuroreport (2008) 0.93
HIV-1 Tat interacts with and regulates the localization and processing of amyloid precursor protein. PLoS One (2013) 0.92
HIV protease inhibitor exposure predicts cerebral small vessel disease. AIDS (2014) 0.92
Amyloid beta accumulation in HIV-1-infected brain: The role of the blood brain barrier. IUBMB Life (2012) 0.91
Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals. Curr Opin Investig Drugs (2010) 0.91
Neuropathology of HAND With Suppressive Antiretroviral Therapy: Encephalitis and Neurodegeneration Reconsidered. Curr HIV/AIDS Rep (2015) 0.90
Endolysosome involvement in HIV-1 transactivator protein-induced neuronal amyloid beta production. Neurobiol Aging (2013) 0.89
Elevated rates of mild cognitive impairment in HIV disease. J Neurovirol (2015) 0.89
Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression. JAMA Neurol (2016) 0.87
APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study. BMC Neurol (2015) 0.86
Brain atrophy in Alzheimer's Disease and aging. Ageing Res Rev (2016) 0.86
ApoE ε4 Is Associated With Cognition, Brain Integrity, and Atrophy in HIV Over Age 60. J Acquir Immune Defic Syndr (2016) 0.83
Human immunodeficiency virus-associated dementia: a link between accumulation of viral proteins and neuronal degeneration. Curr Trends Neurol (2015) 0.82
White matter structure alterations in HIV-1-infected men with sustained suppression of viraemia on treatment. AIDS (2016) 0.82
Role of nuclear medicine in neuroHIV: PET, SPECT, and beyond. Nucl Med Commun (2014) 0.81
Neuroinflammation in treated HIV-positive individuals: A TSPO PET study. Neurology (2016) 0.81
Identifying Neurocognitive Decline at 36 Months among HIV-Positive Participants in the CHARTER Cohort Using Group-Based Trajectory Analysis. PLoS One (2016) 0.80
Metacognition in the behavioral variant of frontotemporal dementia and Alzheimer's disease. Neuropsychology (2014) 0.80
No support for premature central nervous system aging in HIV-1 when measured by cerebrospinal fluid phosphorylated tau (p-tau). Virulence (2016) 0.79
Prevalence of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease, and its relationship with cognitive impairment. Curr Alzheimer Res (2010) 0.78
Aging with HIV-1 Infection: Motor Functions, Cognition, and Attention - A Comparison with Parkinson's Disease. Neuropsychol Rev (2015) 0.78
Psychiatric symptom burden in older people living with HIV with and without cognitive impairment: the UCSF HIV over 60 cohort study. AIDS Care (2017) 0.78
White matter hyperintensities correlate to cognition and fiber tract integrity in older adults with HIV. J Neurovirol (2017) 0.76
Verbal list learning and memory profiles in HIV-infected adults, Alzheimer's disease, and Parkinson's disease: An evaluation of the "cortical hypothesis" of NeuroAIDS. Appl Neuropsychol Adult (2016) 0.76
Progressive Brain Atrophy Despite Persistent Viral Suppression in HIV Over Age 60. J Acquir Immune Defic Syndr (2017) 0.76
HIV/neuroAIDS biomarkers. Prog Neurobiol (2016) 0.76
HIV encephalitis with subcortical tau deposition: imaging pathology in vivo using F-18 THK 5117. Eur J Nucl Med Mol Imaging (2016) 0.75
PET brain imaging in HIV-associated neurocognitive disorders (HAND) in the era of combination antiretroviral therapy. Eur J Nucl Med Mol Imaging (2017) 0.75
Cognitive reserve and neuropsychological functioning in older HIV-infected people. J Neurovirol (2016) 0.75
Brain and liver pathology, amyloid deposition, and interferon responses among older HIV-positive patients in the late HAART era. BMC Infect Dis (2017) 0.75
Neuroimaging correlates of neuropsychiatric symptoms in Alzheimer's disease: a review of 20 years of research. Eur J Neurol (2016) 0.75
Loss of CCR2 expressing non-classical monocytes are associated with cognitive impairment in antiretroviral therapy-naïve HIV-infected Thais. J Neuroimmunol (2015) 0.79
Comparative DNA Methylation Profiling Reveals an Immunoepigenetic Signature of HIV-related Cognitive Impairment. Sci Rep (2016) 0.76